ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Biomeasure Inc, Ipsen Group

Include trials that are no longer recruiting patients.

2 studies were found.
1.No longer recruitingComparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated with Carcinoid Syndrome
Condition: Malignant Carcinoid Syndrome
2.RecruitingDiflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients with Sensitive Small Cell Lung Cancer (SCLC)
Condition: Small Cell Lung Cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act